key: cord-0756518-243c7mno
authors: Johari, Bushra; Abdul Kadir, Roqiah Fatmawati; Abd Ghani, Farihah; Peter, Alan Basil
title: Radiological progression of COVID‐19 organizing pneumonia
date: 2021-05-04
journal: Respirol Case Rep
DOI: 10.1002/rcr2.764
sha: 24b378281683187417432a2e51d5a11169d9b80a
doc_id: 756518
cord_uid: 243c7mno

It has recently been recognized that the clinical course of coronavirus disease 2019 (COVID‐19) and secondary organizing pneumonia (OP) tend to follow a subacute progression of respiratory illness. We present images of radiological progression of COVID‐19 pneumonia and secondary OP.

It has recently been recognized that the clinical course of coronavirus disease 2019 (COVID-19) and secondary organizing pneumonia (OP) tend to follow a subacute progression of respiratory illness. We present images of radiological progression of COVID-19 pneumonia and secondary OP.

A 73-year-old lady with multiple medical comorbidities presented with cough and tested positive for coronavirus disease 2019 (COVID-19). Her symptoms worsened at day 10 where she desaturated to 80% under room air requiring high-flow mask oxygenation. Chest X-ray (CXR) showed bilateral peripheral consolidation. She was given intravenous methylprednisolone (200 mg for four days followed by 150 mg for two days) and subsequently 8 mg dexamethasone. Her supplemental oxygen requirement ceased and she showed symptomatic improvement following treatment; thus she was discharged at day 17 with tapering dose of oral prednisolone. She re-presented again to the hospital at day 22 with dyspnoea. CXR revealed bilateral confluent consolidation and computed tomography (CT) at day 30 revealed changes typical of organizing pneumonia (OP) (Fig. 1) . Cultures for other infections were negative. She was again treated with steroids (oral prednisolone 30 mg once daily for two weeks) and was discharged well from the ward 39 days after her initial diagnosis. The steroid dose was progressively tapered down over three months' time ( Fig. 1) . It has recently been recognized that the clinical course of COVID-19 and secondary OP tend to follow a subacute progression of respiratory compromise. These patients have been called "happy hypoxics," with low oxygen levels in the absence of respiratory distress, thus secondary OP might be missed by those unfamiliar with this entity [1] . In some cases, antiviral therapy was instituted [2] . Re-administration of steroid improved our patient's clinical condition and radiological findings, similar to other recently reported cases [3, 4] . Pattern recognition of OP on CT is vital as it can help expedite proper management, in the absence of histopathological tissue diagnosis. The dose and duration of steroid treatment for secondary OP need to be tailored carefully, as these patients often need higher doses and longer treatment duration [1] .

Appropriate written informed consent was obtained for publication of this case report and accompanying images.

Bushra Johari carried out the literature review and wrote the manuscript draft. Roqiah Fatmawati Abdul Kadir contributed to the manuscript revision and figure preparation. Farihah Abd Ghani and Alan Basil Peter collected the case

SARS-CoV-2 organising pneumonia: 'has there been a widespread failure to identify and treat this prevalent condition in COVID-19?

Radiology-pathology correlation in recovered COVID-19, demonstrating organizing pneumonia

Secondary organizing pneumonia after coronavirus disease 2019: two cases

Sustained coronavirus disease 2019-related organising pneumonia successfully treated with corticosteroid

coronal reconstruction of computed tomography (CT) in lung window (D, E). (A) Day 3 of coronavirus disease 2019 (COVID-19) diagnosis: no evidence of lung consolidation. (B) Day 10: bilateral peripheral consolidations. (C) Day 22: bilateral mid to lower zone consolidations which appeared more confluent. (D) Day 30: perilobular consolidations surrounding ground-glass opacities in keeping with organizing pneumonia (OP). (E) Day 33: OP started to improve following recommencement of steroid therapy